SCHEMBL3926329

SCHEMBL3926329

CCOC(=O)/C=C/c1ccc(CS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.56
CA7 P43166 2/20 0.56
CA9 Q16790 2/20 0.56
CA14 Q9ULX7 2/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CYP3A4 P08684 1/20 0.53
PTGS2 P35354 1/20 0.52
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
AKR1B10 O60218 4/20 0.49
AKR1B1 P15121 4/20 0.49
TTR P02766 1/20 0.49
DPP4 P27487 1/20 0.49
CA4 P22748 1/20 0.49
CA6 P23280 1/20 0.49
CA5A P35218 1/20 0.49
CA5B Q9Y2D0 1/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3926332 1.00 CA12 (0.56) CA12CA7CA9CA14CA1
SCHEMBL3916469 0.88 CA12 (0.53) CA12CA7CA9CA14CA1
SCHEMBL3916466 0.88 CA12 (0.53) CA12CA7CA9CA14CA1
SCHEMBL11104951 0.81 POLB (0.54) CA12CA7CA9CA14CA1
SCHEMBL2771939 0.81 CA12 (0.65) CA12CA7CA9CA14CA1
Ethyl Cinnamate SCHEMBL112445 0.80 CA12 (0.72) CA12CA7CA9CA14CA1
Ethyl Cinnamate SCHEMBL12001792 0.80 CA12 (0.72) CA12CA7CA9CA14CA1
Ethyl Cinnamate SCHEMBL1866942 0.80 CA12 (0.72) CA12CA7CA9CA14CA1
Ethyl Cinnamate SCHEMBL112446 0.80 CA12 (0.72) CA12CA7CA9CA14CA1
SCHEMBL23720157 0.80 HSD11B1 (0.52) LMNAMAPTHSD11B1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495022-B2 α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors SK CHEMICALS CO., LTD. (KR) 2009-02-24 US disclosed
US-20050124679-A1 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors SK CHEMICALS CO., LTD. (KR) 2005-06-09 US disclosed
WO-2003087066-A1 α,β-UNSATURATED HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS SK CHEMICALS, CO., LTD. (KR) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124679-A1 Alpha, beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors HDAC1, HDAC5, HDAC9 CA12 1930/4885CA7 1745/4885CA9 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.